
Therapies that specifically target mutations in a person’s cancer have been much-heralded in recent years, yet cancer cells often find a way around them. To address this, researchers identified a promising combinatorial approach to treating glioblastomas, the most common form of primary brain cancer.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/WJ2UHMwdQPY/150508140258.htm